News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
499,436 Results
Type
Article (9998)
Company Profile (160)
Press Release (489276)
Multimedia
Podcasts (19)
Webinars (7)
Section
Business (171286)
Career Advice (368)
Deals (26354)
Drug Delivery (16)
Drug Development (54228)
Employer Resources (22)
FDA (9932)
Job Trends (8943)
News (244060)
Policy (18333)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (598)
Accelerated approval (27)
ADA (21)
Adcomms (1)
Allergies (103)
Alliances (34400)
ALS (120)
Alzheimer's disease (1023)
Antibody-drug conjugate (ADC) (332)
Approvals (10576)
Artificial intelligence (388)
ASCO (167)
Autoimmune disease (241)
Automation (34)
Bankruptcy (271)
Belgium (4)
Best Places to Work (7129)
BIO (41)
Biologics (14)
BIOSECURE Act (3)
Biosimilars (138)
BioSpace Insights (27)
Biotechnology (101)
Bispecific (3)
Bladder cancer (144)
Brain cancer (38)
Breast cancer (535)
Cancer (4008)
Cardiovascular disease (241)
Career advice (297)
Career pathing (2)
CAR-T (197)
CDC (3)
CDMO (28)
Celiac Disease (1)
Cell therapy (545)
Cervical cancer (39)
Clinical research (49079)
Collaboration (1436)
Commercialization (6)
Company closure (4)
Compensation (1567)
Complete response letters (36)
COVID-19 (895)
CRISPR (71)
C-suite (911)
Cystic fibrosis (92)
Data (6152)
Denatured (10)
Depression (116)
Dermatology (80)
Diabetes (379)
Diagnostics (4374)
Digital health (39)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (195)
Drug pricing (17)
Drug shortages (2)
Duchenne muscular dystrophy (194)
Earnings (74431)
Editorial (7)
Employer branding (3)
Employer resources (20)
Events (89858)
Executive appointments (778)
FDA (12760)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (1113)
Gene editing (144)
Generative AI (14)
Gene therapy (382)
GLP-1 (358)
Government (1057)
Grass and pollen (2)
Guidances (285)
Healthcare (9571)
Hematology (95)
HIV (57)
Huntington's disease (25)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (72)
Immunology and inflammation (150)
Immuno-oncology (76)
Indications (170)
Infectious disease (1105)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (90)
Intellectual property (275)
Interviews (48)
IPO (12592)
IRA (7)
Job creations (2139)
Job search strategy (281)
JPM (5)
Kidney cancer (21)
Kidney disease (49)
Labor market (12)
Layoffs (109)
Leadership (4)
Legal (5278)
Licensing (25)
Liver cancer (50)
Longevity (23)
Lung cancer (573)
Lung diease (8)
Lymphoma (269)
Machine learning (33)
Management (7)
Manufacturing (635)
Marketing (9)
MASH (122)
Medical affairs (2)
Medical device (8780)
Medtech (8943)
Mergers & acquisitions (14848)
Metabolic disorders (792)
mRNA (84)
Multiple sclerosis (111)
NASH (4)
Neurodegenerative disease (252)
Neuropsychiatric disorders (52)
Neuroscience (2002)
NextGen: Class of 2026 (3336)
Non-profit (959)
Now hiring (17)
Obesity (265)
Opinion (32)
Ovarian cancer (171)
Pain (185)
Pancreatic cancer (229)
Parkinson's disease (222)
Partnered (15)
Patents (524)
Patient advocacy (1)
Patient recruitment (551)
Patient selection (15)
Peanut (34)
People (43071)
Peptides (5)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (15986)
Phase 2 (21998)
Phase 3 (14837)
Pipeline (8165)
Policy (33)
Postmarket research (1568)
Preclinical (6758)
Press Release (34)
Prostate cancer (199)
Psychedelics (14)
Radiopharmaceuticals (210)
Rare diseases (655)
Real estate (3259)
Recruiting (10)
Regenerative medicine (7)
Regulatory (15414)
Reports (27)
Research institute (691)
Resumes & cover letters (52)
Rett syndrome (44)
RNA editing (11)
RSV (51)
Schizophrenia (114)
Series A (206)
Series B (144)
Service/supplier (5)
Sickle cell disease (65)
Special edition (3)
Spinal muscular atrophy (92)
Sponsored (6)
Startups (2292)
Stomach cancer (5)
Substance use disorders (16)
Supply chain (53)
Tariffs (2)
The Weekly (9)
Vaccines (366)
Venture capital (40)
Weight loss (99)
Wet AMD (1)
Women's health (95)
Worklife (1)
Date
Today (7)
Last 7 days (356)
Last 30 days (1490)
Last 365 days (19872)
2026 (14840)
2025 (19987)
2024 (23639)
2023 (27241)
2022 (35537)
2021 (38230)
2020 (34485)
2019 (24023)
2018 (18159)
2017 (19358)
2016 (18550)
2015 (24833)
2014 (22073)
2013 (18596)
2012 (20682)
2011 (20861)
2010 (20687)
Location
Africa (250)
Alabama (83)
Alaska (2)
Arizona (317)
Arkansas (10)
Asia (19132)
Australia (2289)
California (12858)
Canada (3337)
China (629)
Colorado (516)
Connecticut (443)
Delaware (222)
Europe (27356)
Florida (1899)
Georgia (397)
Hawaii (4)
Idaho (47)
Illinois (763)
India (59)
Indiana (335)
Iowa (16)
Japan (445)
Kansas (114)
Kentucky (34)
Louisiana (29)
Maine (27)
Maryland (1265)
Massachusetts (8412)
Michigan (320)
Minnesota (593)
Mississippi (5)
Missouri (86)
Montana (20)
Nebraska (11)
Nevada (126)
New Hampshire (63)
New Jersey (2799)
New Mexico (12)
New York (2963)
North Carolina (1344)
North Dakota (4)
Northern California (6497)
Ohio (313)
Oklahoma (15)
Oregon (20)
Pennsylvania (2344)
Puerto Rico (25)
Rhode Island (31)
South America (421)
South Carolina (78)
South Dakota (1)
Southern California (5317)
Tennessee (131)
Texas (2100)
United States (41465)
Utah (381)
Vermont (1)
Virginia (166)
Washington D.C. (42)
Washington State (1023)
West Virginia (2)
Wisconsin (92)
Wyoming (1)
499,436 Results for "prometheus bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b miss
The anti-TL1A antibody from Merck’s 2023 Prometheus buy delivered positive mid-stage results in a skin condition but failed in a certain type of lung disease, the Big Pharma revealed alongside second-quarter earnings.
August 4, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
Finance & Accounting for Bioscience West debuts in San Diego this December
Discover innovative financial strategies and expert guidance from leading bioscience finance executives at this first-ever West Coast forum.
September 18, 2026
·
1 min read
Press Releases
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
·
6 min read
Press Releases
Swiss Bioscience and OrganTech sign MOU to explore strategic collaboration in hair regeneration in Europe
Swiss Bioscience selected as OrganTech’s preferred strategic partner in Europe for regulatory development, GMP manufacturing, clinical research, and potential commercialization of the conditioned medium technology.
September 23, 2026
·
1 min read
Deals
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) (NASDAQ: RXDX) acquisition.
June 16, 2023
·
6 min read
Press Releases
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
August 4, 2026
·
14 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Slingshot Biosciences Announces Leadership Transition
Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead the Company into Its Next Chapter
September 25, 2026
·
1 min read
Press Releases
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
August 6, 2026
·
10 min read
Deals
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.
April 16, 2023
·
12 min read
1 of 49,944
Next
